Trial intelligence / Profile preview

Safety and efficacy of switching to DuoTrav from prior mono- or two-drug therapy in Germany

2006-005237-38Phase 4Completed

Sponsor
Alcon Inc.
Start
Aug 2007
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of travoprost in open-angle glaucoma (OAG), sponsored by Alcon Inc.. Started Aug 2007; status: completed.

02

Drugs

travoprost
03

Conditions

open-angle glaucoma (OAG)

Beyond the preview

Go deeper on 2006-005237-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005237-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call